XML 57 R39.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Fair Value Measurements (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Fair Value Disclosures [Abstract] |
Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis | Below is a summary of the assets and liabilities that are measured at fair value on a recurring basis and also represents the carrying amount on the Company’s consolidated balance sheets:
| At December 31, 2023 | Total |  | Quoted Prices in Active Markets for Identical Assets (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Unobservable Inputs (Level 3) |
| Fixed maturity investments trading |  |  |  |  |  |  |  |
| U.S. treasuries | $ | 10,060,203 |  |  | $ | 10,060,203 |  |  | $ | — |  |  | $ | — |  |
| Corporate (1) | 6,499,075 |  |  | — |  |  | 6,499,075 |  |  | — |  |
| Asset-backed | 1,491,695 |  |  | — |  |  | 1,491,695 |  |  | — |  |
| Residential mortgage-backed | 1,420,362 |  |  | — |  |  | 1,420,362 |  |  | — |  |
| Agencies | 489,117 |  |  | — |  |  | 489,117 |  |  | — |  |
| Non-U.S. government | 483,576 |  |  | — |  |  | 483,576 |  |  | — |  |
| Commercial mortgage-backed | 433,080 |  |  | — |  |  | 433,080 |  |  | — |  |
| Total fixed maturity investments trading | 20,877,108 |  |  | 10,060,203 |  |  | 10,816,905 |  |  | — |  |
| Short term investments | 4,604,079 |  |  | 130,232 |  |  | 4,473,847 |  |  | — |  |
| Equity investments | 106,766 |  |  | 106,766 |  |  | — |  |  | — |  |
| Other investments |  |  |  |  |  |  |  |
| Catastrophe bonds | 1,942,199 |  |  | — |  |  | 1,942,199 |  |  | — |  |
| Term loans | 97,658 |  |  | — |  |  | — |  |  | 97,658 |  |
| Direct private equity investments | 59,905 |  |  | — |  |  | — |  |  | 59,905 |  |
|  | 2,099,762 |  |  | — |  |  | 1,942,199 |  |  | 157,563 |  |
| Fund investments (2) | 1,415,804 |  |  | — |  |  | — |  |  | — |  |
| Total other investments | 3,515,566 |  |  | — |  |  | 1,942,199 |  |  | 157,563 |  |
| Other assets and (liabilities) |  |  |  |  |  |  |  |
| Assumed and ceded (re)insurance contracts (3) | (515) |  |  | — |  |  | — |  |  | (515) |  |
| Derivative assets (4) | 44,724 |  |  | 16,701 |  |  | 28,023 |  |  | — |  |
| Derivative liabilities (4) | (29,992) |  |  | (10,372) |  |  | (19,620) |  |  | — |  |
| Total other assets and (liabilities) | 14,217 |  |  | 6,329 |  |  | 8,403 |  |  | (515) |  |
|  | $ | 29,117,736 |  |  | $ | 10,303,530 |  |  | $ | 17,241,354 |  |  | $ | 157,048 |  |
(1)Corporate fixed maturity investments include non-U.S. government-backed corporate fixed maturity investments. (2)Fund investments, which may include private equity funds, private credit funds, and hedge funds are measured at fair value using the net asset value per share (or its equivalent) as a practical expedient and have not been classified in the fair value hierarchy. The fair value presented in this table is provided to permit reconciliation of the fair value hierarchy to the amounts presented in the consolidated balance sheet. (3)Included in assumed and ceded (re)insurance contracts at December 31, 2023 was $2.2 million of other assets and $2.7 million of other liabilities. (4)Refer to “Note 19. Derivative Instruments” for additional information related to the fair value, by type of contract, of derivatives entered into by the Company.
| At December 31, 2022 | Total |  | Quoted Prices in Active Markets for Identical Assets (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Unobservable Inputs (Level 3) |
| Fixed maturity investments trading |  |  |  |  |  |  |  |
| U.S. treasuries | $ | 7,180,129 |  |  | $ | 7,180,129 |  |  | $ | — |  |  | $ | — |  |
| Corporate (1) | 4,390,568 |  |  | — |  |  | 4,390,568 |  |  | — |  |
| Agencies | 395,149 |  |  | — |  |  | 395,149 |  |  | — |  |
| Non-U.S. government | 383,838 |  |  | — |  |  | 383,838 |  |  | — |  |
| Residential mortgage-backed | 710,429 |  |  | — |  |  | 710,429 |  |  | — |  |
| Commercial mortgage-backed | 213,987 |  |  | — |  |  | 213,987 |  |  | — |  |
| Asset-backed | 1,077,302 |  |  | — |  |  | 1,077,302 |  |  | — |  |
| Total fixed maturity investments trading | 14,351,402 |  |  | 7,180,129 |  |  | 7,171,273 |  |  | — |  |
| Short term investments | 4,669,272 |  |  | — |  |  | 4,669,272 |  |  | — |  |
| Equity investments | 625,058 |  |  | 625,058 |  |  | — |  |  | — |  |
| Other investments |  |  |  |  |  |  |  |
| Catastrophe bonds | 1,241,468 |  |  | — |  |  | 1,241,468 |  |  | — |  |
| Term loans | 100,000 |  |  | — |  |  | — |  |  | 100,000 |  |
| Direct private equity investments | 66,780 |  |  | — |  |  | — |  |  | 66,780 |  |
|  | 1,408,248 |  |  | — |  |  | 1,241,468 |  |  | 166,780 |  |
| Fund investments (2) | 1,086,706 |  |  | — |  |  | — |  |  | — |  |
| Total other investments | 2,494,954 |  |  | — |  |  | 1,241,468 |  |  | 166,780 |  |
| Other assets and (liabilities) |  |  |  |  |  |  |  |
| Assumed and ceded (re)insurance contracts (3) | (1,832) |  |  | — |  |  | — |  |  | (1,832) |  |
| Derivative assets (4) | 44,400 |  |  | 387 |  |  | 44,013 |  |  | — |  |
| Derivative liabilities (4) | (7,560) |  |  | (2,008) |  |  | (5,552) |  |  | — |  |
| Total other assets and (liabilities) | 35,008 |  |  | (1,621) |  |  | 38,461 |  |  | (1,832) |  |
|  | $ | 22,175,694 |  |  | $ | 7,803,566 |  |  | $ | 13,120,474 |  |  | $ | 164,948 |  |
(1)Corporate fixed maturity investments include non-U.S. government-backed corporate fixed maturity investments. (2)Fund investments, which may include private equity funds, private credit funds, and hedge funds are measured at fair value using the net asset value per share (or its equivalent) as a practical expedient and have not been classified in the fair value hierarchy. The fair value presented in this table is provided to permit reconciliation of the fair value hierarchy to the amounts presented in the consolidated balance sheet. (3)Included in assumed and ceded (re)insurance contracts at December 31, 2022 was $3.5 million of other assets and $5.3 million of other liabilities. (4)Refer to “Note 19. Derivative Instruments” for additional information related to the fair value, by type of contract, of derivatives entered into by the Company.
Schedule of Quantitative Information Used as Level 3 Inputs | Below is a summary of quantitative information regarding the significant unobservable inputs (Level 3) used in determining the fair value of assets and liabilities measured at fair value on a recurring basis:
| At December 31, 2023 | Fair Value (Level 3) |  | Valuation Technique |  | Unobservable Inputs |  |  |  |  |  | Weighted Average or Actual |
| Other investments |  |  |  |  |  |  |  |  |  |  |  |
| Direct private equity investments | $ | 59,905 |  |  | Internal valuation model |  | Discount rate |  |  |  |  |  | 10.0 | % |
|  |  |  |  |  | Liquidity discount |  |  |  |  |  | 15.0 | % |
| Term loans | 97,658 |  |  | Discounted cash flow |  | Credit spread adjustment |  |  |  |  |  | 0.2 | % |
|  |  |  |  |  | Risk premium |  |  |  |  |  | 2.6 | % |
| Total other investments | 157,563 |  |  |  |  |  |  |  |  |  |  |  |
| Other assets and (liabilities) |  |  |  |  |  |  |  |  |  |  |  |
| Assumed and ceded (re)insurance contracts | (515) |  |  | Internal valuation model |  | Net undiscounted cash flows |  |  |  |  |  | $ | 12,478 |  |
|  |  |  |  |  | Expected loss ratio |  |  |  |  |  | 2.3 | % |
|  |  |  |  |  | Discount rate |  |  |  |  |  | 20.7 | % |
| Total other assets and (liabilities) | (515) |  |  |  |  |  |  |  |  |  |  |  |
| Total assets and (liabilities) measured at fair value on a recurring basis using Level 3 inputs | $ | 157,048 |  |  |  |  |  |  |  |  |  |  |  |
| At December 31, 2022 | Fair Value (Level 3) |  | Valuation Technique |  | Unobservable Inputs |  |  |  |  |  | Weighted Average or Actual |
| Other investments |  |  |  |  |  |  |  |  |  |  |  |
| Direct private equity investments | $ | 66,780 |  |  | Internal valuation model |  | Discount rate |  |  |  |  |  | 7.5 | % |
|  |  |  |  |  | Liquidity discount |  |  |  |  |  | 15.0 | % |
| Term loans | 100,000 |  |  | Discounted cash flow |  | Credit spread adjustment |  |  |  |  |  | 0.2 | % |
|  |  |  |  |  | Risk premium |  |  |  |  |  | 2.6 | % |
| Total other investments | 166,780 |  |  |  |  |  |  |  |  |  |  |  |
| Other assets and (liabilities) |  |  |  |  |  |  |  |  |  |  |  |
| Assumed and ceded (re)insurance contracts | (1,832) |  |  | Internal valuation model |  | Net undiscounted cash flows |  |  |  |  |  | $ | 14,734 |  |
|  |  |  |  |  | Expected loss ratio |  |  |  |  |  | 5.8 | % |
|  |  |  |  |  | Discount rate |  |  |  |  |  | 4.0 | % |
| Total other assets and (liabilities) | (1,832) |  |  |  |  |  |  |  |  |  |  |  |
| Total assets and (liabilities) measured at fair value on a recurring basis using Level 3 inputs | $ | 164,948 |  |  |  |  |  |  |  |  |  |  |  |
Schedule of Assets and Liabilities Measured at Fair Value an a Recurring Basis Using Level 3 Inputs | Below is a reconciliation of the beginning and ending balances, for the periods shown, of assets and liabilities measured at fair value on a recurring basis using Level 3 inputs.
|  |  |  | Other Investments |  |  |  |  |
|  |  |  | Direct Private Equity Investments |  | Term Loans |  | Other Assets and (Liabilities) |  | Total |
| Balance - January 1, 2023 |  |  | $ | 66,780 |  |  | $ | 100,000 |  |  | $ | (1,832) |  |  | $ | 164,948 |  |
| Included in net investment income |  |  | 250 |  |  | — |  |  | — |  |  | 250 |  |
| Included in net realized and unrealized gains (losses) on investments |  |  | (7,120) |  |  | — |  |  | — |  |  | (7,120) |  |
| Included in other income (loss) |  |  | — |  |  | — |  |  | (492) |  |  | (492) |  |
| Total foreign exchange gains (losses) |  |  | (5) |  |  | — |  |  | — |  |  | (5) |  |
| Purchases |  |  | — |  |  | — |  |  | 1,809 |  |  | 1,809 |  |
| Settlements |  |  | — |  |  | (2,342) |  |  | — |  |  | (2,342) |  |
| Balance - December 31, 2023 |  |  | $ | 59,905 |  |  | $ | 97,658 |  |  | $ | (515) |  |  | $ | 157,048 |  |
|  |  | Other Investments |  |  |  |  |
|  |  | Direct Private Equity Investments |  | Term Loans |  | Other Assets and (Liabilities) |  | Total |
| Balance - January 1, 2022 |  | $ | 88,373 |  |  | $ | 74,850 |  |  | $ | (4,727) |  |  | $ | 158,496 |  |
| Included in net investment income |  | 188 |  |  | 605 |  |  | — |  |  | 793 |  |
| Included in net realized and unrealized gains (losses) on investments |  | (26,893) |  |  | — |  |  | — |  |  | (26,893) |  |
| Included in other income (loss) |  | — |  |  | — |  |  | 2,682 |  |  | 2,682 |  |
| Total foreign exchange gains (losses) |  | (11) |  |  | — |  |  | — |  |  | (11) |  |
| Purchases |  | 5,123 |  |  | 25,000 |  |  | 213 |  |  | 30,336 |  |
| Settlements |  | — |  |  | (455) |  |  | — |  |  | (455) |  |
| Balance - December 31, 2022 |  | $ | 66,780 |  |  | $ | 100,000 |  |  | $ | (1,832) |  |  | $ | 164,948 |  |
Schedule of Assets and Liabilities Measured at Fair Value an a Recurring Basis Using Level 3 Inputs | Below is a reconciliation of the beginning and ending balances, for the periods shown, of assets and liabilities measured at fair value on a recurring basis using Level 3 inputs.
|  |  |  | Other Investments |  |  |  |  |
|  |  |  | Direct Private Equity Investments |  | Term Loans |  | Other Assets and (Liabilities) |  | Total |
| Balance - January 1, 2023 |  |  | $ | 66,780 |  |  | $ | 100,000 |  |  | $ | (1,832) |  |  | $ | 164,948 |  |
| Included in net investment income |  |  | 250 |  |  | — |  |  | — |  |  | 250 |  |
| Included in net realized and unrealized gains (losses) on investments |  |  | (7,120) |  |  | — |  |  | — |  |  | (7,120) |  |
| Included in other income (loss) |  |  | — |  |  | — |  |  | (492) |  |  | (492) |  |
| Total foreign exchange gains (losses) |  |  | (5) |  |  | — |  |  | — |  |  | (5) |  |
| Purchases |  |  | — |  |  | — |  |  | 1,809 |  |  | 1,809 |  |
| Settlements |  |  | — |  |  | (2,342) |  |  | — |  |  | (2,342) |  |
| Balance - December 31, 2023 |  |  | $ | 59,905 |  |  | $ | 97,658 |  |  | $ | (515) |  |  | $ | 157,048 |  |
|  |  | Other Investments |  |  |  |  |
|  |  | Direct Private Equity Investments |  | Term Loans |  | Other Assets and (Liabilities) |  | Total |
| Balance - January 1, 2022 |  | $ | 88,373 |  |  | $ | 74,850 |  |  | $ | (4,727) |  |  | $ | 158,496 |  |
| Included in net investment income |  | 188 |  |  | 605 |  |  | — |  |  | 793 |  |
| Included in net realized and unrealized gains (losses) on investments |  | (26,893) |  |  | — |  |  | — |  |  | (26,893) |  |
| Included in other income (loss) |  | — |  |  | — |  |  | 2,682 |  |  | 2,682 |  |
| Total foreign exchange gains (losses) |  | (11) |  |  | — |  |  | — |  |  | (11) |  |
| Purchases |  | 5,123 |  |  | 25,000 |  |  | 213 |  |  | 30,336 |  |
| Settlements |  | — |  |  | (455) |  |  | — |  |  | (455) |  |
| Balance - December 31, 2022 |  | $ | 66,780 |  |  | $ | 100,000 |  |  | $ | (1,832) |  |  | $ | 164,948 |  |
Schedule of the Balances the Company has Elected to Account for at Fair Value | Below is a summary of the balances the Company has elected to account for at fair value:
| At December 31, | 2023 |  | 2022 |
| Other investments | $ | 3,515,566 |  |  | $ | 2,494,954 |  |
| Other assets | $ | 2,227 |  |  | $ | 3,499 |  |
| Other liabilities | $ | 2,742 |  |  | $ | 5,331 |  |
Schedule of Other Investments Measured Using Net Asset Valuations | The table below shows the Company’s portfolio of other investments measured using net asset valuations as a practical expedient:
| At December 31, 2023 | Fair Value |  | Unfunded Commitments |  | Redemption Frequency |  | Redemption Notice Period (Minimum Days) |  | Redemption Notice Period (Maximum Days) |
| Private credit funds | $ | 982,016 |  |  | $ | 949,135 |  |  | See below |  | See below |  | See below |
| Private equity funds | 433,788 |  |  | 673,778 |  |  | See below |  | See below |  | See below |
| Total other investments measured using net asset valuations | $ | 1,415,804 |  |  | $ | 1,622,913 |  |  |  |  |  |  |  |
| At December 31, 2022 | Fair Value |  | Unfunded Commitments |  | Redemption Frequency |  | Redemption Notice Period (Minimum Days) |  | Redemption Notice Period (Maximum Days) |
| Private credit funds | $ | 771,383 |  |  | $ | 714,302 |  |  | See below |  | See below |  | See below |
| Private equity funds | 315,323 |  |  | 493,155 |  |  | See below |  | See below |  | See below |
| Total other investments measured using net asset valuations | $ | 1,086,706 |  |  | $ | 1,207,457 |  |  |  |  |  |  |  |
Schedule of Variable Interest Entities | The following table summarizes the aggregate carrying amount of the unconsolidated fund investments in VIEs, as well as our maximum exposure to loss associated with these VIEs:
|  | Maximum Exposure to Loss
| At December 31, 2023 | Carrying amount |  | Unfunded Commitments |  | Total
| Other investments | $ | 1,251,799 |  |  | $ | 1,550,452 |  |  | $ | 2,802,251 |
| At December 31, 2022 |  |  |  |  |
| Other investments | $ | 916,248 |  |  | $ | 1,148,630 |  |  | $ | 2,064,878 |

X
- Definition Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c) -SubTopic 10 -Topic 820 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3 + Details
Name: | us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of investments in certain entities that calculate net asset value per share or equivalent measured at fair value on a recurring or nonrecurring basis. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (a) -SubTopic 10 -Topic 820 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-6A + Details
Name: | us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c) -SubTopic 10 -Topic 820 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3 + Details
Name: | us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 820 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//820/tableOfContent + Details
Name: | us-gaap_FairValueMeasurementInputsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of information about asset and liability measured at fair value under fair value option. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-30 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-31 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-32 + Details
Name: | us-gaap_FairValueOptionQuantitativeDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 5A -Publisher FASB -URI https://asc.fasb.org//1943274/2147481203/810-10-50-5A Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481203/810-10-50-9 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481203/810-10-50-4 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481203/810-10-50-6 + Details
Name: | us-gaap_ScheduleOfVariableInterestEntitiesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration